Is the Boom in Canada’s Marijuana Stocks Over?

As Aphria Inc. (TSX:APHA) stock comes under pressure, investors should focus on other top marijuana producers, such as Canopy Growth Corp. (TSX:WEED)(NYSE:CGS).

| More on:
Businessman looking at a red arrow crashing through the floor

Image source: Getty Images.

Canada’s marijuana stocks have been under pressure since the country opened up its market for the recreational use in October. The steep decline in the share values of top producers have investors wondering if the legalization boom for the pot producers is over.

The latest shock to marijuana stocks came when an investigative report by a short-seller, Quintessential Capital Management, called Aphria Inc. (TSX:APHA) a “black hole” due to the company’s questionable deal-making in Latin America.

Gabriel Grego, the founder of Quintessential, released a report this week claiming that Aphria, one of Canada’s largest pot producers, was overpaid to acquire companies held by insiders in South America and the Caribbean.

The short seller also alleged that Aphria purchased companies from SOL Global Investments Corp., which had acquired them shortly before at a “significantly lower” price from three Canadian shell companies linked to Andy DeFrancesco, chairman of SOL and adviser to Aphria.

This scathing report by Grego, who believes that Aphria stock is worth zero, caused a massive plunge in Aphria stock that lost more than half of its value this week and was trading $4.65 a share at the time of writing.

Implications for other marijuana stocks

Without delving into the merits and demerits of this report, one impact this allegation will have on other pot stocks is that it will slow their recovery and prompt investors to scrutinize the sector more vigorously. Analysts’ reaction to this report shows that the market has taken these allegations seriously.

BMO analyst Tamy Chen cut her price target for Aphria to $9 from $22, citing “considerable uncertainty surrounding the stock.” Martin Landry, analyst at GMP Securities, put his rating and price target for Aphria under review.

In my view, this negative development is specific to Aphria, and investors shouldn’t paint the every name with the same brush. Other larger producers, such as Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) in which Constellation Brands has a large stake, still offer a solid investment case.

After the Aphria setback, we may see the current downturn prolonging in an environment when investors are generally shunning the riskier assets. But over the long run, the large cap marijuana stocks, especially Canopy Growth, continue to remain a solid investment due to their global operations and the leading market position in Canada.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no position in the companies mentioned.

More on Investing

Index funds
Investing

Top 3 S&P 500 Index Funds

Here are my top three picks when it comes to investing in the S&P 500 for Canadians.

Read more »

calculate and analyze stock
Dividend Stocks

The 5 Best Low-Risk Investments for Canadians

If you're wanting to keep things low risk in this volatile market, these are the top five places where investors…

Read more »

Payday ringed on a calendar
Dividend Stocks

How to Build a Bulletproof Monthly Passive-Income Portfolio in 2024 With Just $25,000

Invest in quality monthly dividend ETFs such as the XDIV to create a recurring and reliable passive-income stream for life.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, April 19

The main TSX index seems on track to post another losing week as it currently trades with 0.9% week-to-date losses.

Read more »

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »